In this issue:
- Tricuspid valve replacement outcomes by baseline tricuspid regurgitation severity
- Aspirin + oral anticoagulants in patients with chronic coronary syndrome
- BP-lowering efficacy of antihypertensive drugs and their combinations
- SGLT2 inhibitor + spironolactone for HFpEF
- Lp(a) levels and secondary outcomes in patients with ACS
- TAVI for patients with moderate AS
- Early aortic valve replacement in patients with asymptomatic severe AS
- Prediction of ventricular arrhythmic outcomes in suspected cardiac sarcoidosis
- Coffee and cardiovascular disease
- PCD-CT for the detection of in-stent restenosis
Please login below to download this issue (PDF)